RCUS Arcus Biosciences, Inc.
$24.59▼ -5.97%
Healthcare
Other
After hours
$24.35▼ -0.98%
Sep 11, 6:40 PM ET
Volume 4.28M
Avg Volume (10D) 1.28M
Key Metrics & Fundamentals
Market Cap
$3.09B
P/E Ratio
–
Div Yield
–%
52W Range
11.30 - 31.74
% vs 50 MA
-14.97%
% vs 200 MA
-0.59%
RSI-14
28.1
MACD Histogram
-0.5900
Beta (1Y vs SPY)
1.83
Free Cash Flow
-$119.00M
Gross Rev
$41.00M
Gross Profit
$41.00M
EBITDA
-$85.00M
COGS
–
Operating Exp
$137.00M
Operating Income
-$96.00M
EBIT
-$96.00M
Pretax Income
-$91.00M
Net Income
-$91.00M
EPS (Diluted)
-0.72
Price & Volume History
Loading chart…
Recent News
Arcus Biosciences Announces New Employment Inducement Grants
Business Wire · Sep 9, 2026 8:35 PM
Arcus Biosciences to Participate in Three Upcoming Investor Conferences
Business Wire · Aug 26, 2026 8:05 PM
Could Arcus Biosciences (RCUS) and Summit Therapeutics (SMMT)’s Cancer Drug Partnership Create a New Treatment Standard?
Insider Monkey · Aug 14, 2026 12:03 AM
Arcus Biosciences (RCUS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 1:14 AM
Arcus Biosciences' Casdatifan Therapy Could be Launched in 2028, Morgan Stanley Says
MT Newswires · Aug 10, 2026 4:01 PM
Morgan Stanley Adjusts Price Target on Arcus Biosciences to $23 From $22, Maintains Equalweight Rating
MT Newswires · Aug 10, 2026 9:41 AM
Arcus Biosciences Q2 Earnings Call Highlights
MarketBeat · Aug 9, 2026 3:03 AM
Arcus Biosciences (RCUS) Stock Gets Fair Value Bump After Casdatifan Optimism
Simply Wall St. · Aug 8, 2026 5:10 AM
Wedbush Adjusts Price Target on Arcus Biosciences to $43 From $41, Maintains Outperform Rating
MT Newswires · Aug 6, 2026 1:01 PM
Arcus Biosciences, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 6, 2026 12:30 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See RCUS's money flow as a full page
Social Sentiment
No Reddit posts found for RCUS.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.